Cancer Immunology Research

Aims & Scope

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials.

The journal disseminates knowledge of immunology to the cancer research community, catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes.

Papers are stringently reviewed, and specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and clinical investigations.

The journal's special features include "Masters of Immunology"—primers by leading immunologists—and "Cancer Immunology at the Crossroads"—perspectives that highlight the intersection of immunology with other areas of cancer research and allied disciplines.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	8.2
2024	8.10

SJR (SCImago Journal Rank)

Year	Value
2024	3.630

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	147

Journal Rank

Year	Value
2024	505

Journal Citation Indicator

Year	Value
2024	2893

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Immunology and Microbiology, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Myeloid-Derived Suppressor Cells

  Citation: 1491

  Authors: Dmitry I.

• PD-L1 Expression in Triple-Negative Breast Cancer

  Citation: 1096

  Authors: Elizabeth A., Anne V., Funda, Na, Yun, Susan, Xiaoping, Ying, Ana M., Argun, Akhil, Michael, Patrick, Padmanee, Jennifer K., Jeffrey J., Gheath

• NF-κB, an Active Player in Human Cancers

  Citation: 1010

  Authors: Yifeng, Shen, Inder M.

• Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells

  Citation: 748

  Authors: Mark J., John J., Michael, Karla A., Timothy, Mohan, Alan J.

• Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies

  Citation: 739

  Authors: Gregory L., Andrew R., Marcela V., Drew A., Michael C., Gabriela, Anne, Yangbing, Bruce L., Steven M., Michael, Carl H.

• Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures

  Citation: 738

  Authors: Dongqiang, Meiyi, Rui, Jingwen, Huiying, Min, Jianping, Yulin, Jinjun, Wangjun

• The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies

  Citation: 670

  Authors: Leisha A., Gary

• An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non–Small Cell Lung Cancer

  Citation: 556

  Authors: Encouse B., Sandra, Peter B., Abraham, Silvia C.

• Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen

  Citation: 556

  Authors: Andrew B., Christopher J., Christina M., Thomas R., Brian J., Esteban, Theodore L., Charles G.

• Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity

  Citation: 541

  Authors: Liang-Chuan S., Albert, John, Jing, Rajrupa S., Veena, Michael, Cody E., Laura A., Amy C., Charalambos C., Carl H., Ellen, Steven M.

---